(Q43246850)
Statements
XLF-III-43, a novel coumarin-aspirin compound, prevents diabetic nephropathy in rats via inhibiting advanced glycation end products (English)
Hongyan Li
Xuguang Zheng
Hongbo Wang
Hongqi Xin
4 November 2009
scientific article published on 4 November 2009